Shares of micro-cap biotech Conatus Pharmaceuticals Inc (NASDAQ: CNAT) were sinking further into penny stock territory Tuesday after two announcements made Monday after the market close. Conatus said …
More NASH Disappointment Forces Conatus To Explore Strategic Alternatives Videos